Eli Lilly confirms probe by New York's Attorney General over insulin prices

  • 📰 CNBC
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 72%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Eli Lily, the maker of blockbuster diabetes treatment Humalog, has been under scrutiny from U.S. lawmakers and the White House over the high cost of its life-saving medication.

Attorney general offices in Mississippi, Washington D.C., California, Florida, Hawaii, and Nevada are also seeking information on its pricing, Eli Lilly said in the filing. It also received a civil investigative demands from attorney general offices in Washington and New Mexico.Earlier this week, drugmaker Sanofi disclosed that it, Eli Lilly and Novo Nordisk had received subpoena from New York's AG.

The Centers for Disease Control and Prevention estimates more than 30 million Americans have diabetes. The annual cost of insulin for people with Type 1 diabetes in the U.S.from 2012 to 2016 to $5,700 from $2,900, according to an analysis by the nonprofit Health Care Cost Institute. Eli Lilly's Humalog makes $3 billion in annual sales.

Drug companies have instead placed blamed on pharmacy benefit managers, sometimes called middlemen, for the sticker shock some patients see at the counter. Drugmakers argue that PBMs should pass the rebates negotiated with manufactures along to patients.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in HEALTH

Health Health Latest News, Health Health Headlines